ADTAB 3 Tablets 48 mg Cats 2-8 kg

Veterinary antiparasitic in chewable tablets based on lotilaner, against fleas and ticks in cats from 2 to 8 kg. Pack of 3 tablets.
In stock, ready to ship
105723148
€22.28
Tax included

  • Express delivery: in 24/48 hours
    Standard in 3-5 working days
  • Shipping
    Standard €6.50, express €9.00
    Sardinia, Venice and minor islands: €20.00
  • Returns within 14 days
    Right of withdrawal guaranteed
  • Secure payments
    Visa, Mastercard, American Express, PayPal, PayPal in 3 rate, Google Pay, Klarna, Bonifico

Need help? Contact us

Description

Name

ADTAB CHEWABLE TABLETS FOR CATS

Pharmacotherapeutic Category

Ectoparasiticides for systemic use.

Active Substances

Active substance per chewable tablet. AdTab chewable tablets for cats (0.5-2.0 kg). Lotilaner: 12 mg. AdTab chewable tablets for cats (>2.0-8.0 kg). Lotilaner: 48 mg.

Excipients

Yeast powder (flavouring), silicified microcrystalline cellulose, powdered cellulose, lactose monohydrate, povidone K30, crospovidone, sodium lauryl sulphate, vanillin (flavouring), colloidal anhydrous silica, magnesium stearate.

Indications

For the treatment of flea and tick infestations in cats. This veterinary medicinal product provides immediate and persistent flea-killing (Ctenocephalides felis and C. canis) and tick-killing (Ixodes ricinus) activity for 1 month. Fleas and ticks must attach to the host and start feeding to be exposed to the active substance.

Contraindications/Adverse Effects

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

Safety in the Target Species

No adverse reactions were observed following oral administration to 8-week-old kittens weighing 0.5 kg that were treated with doses more than 5 times the maximum recommended dose (130 mg lotilaner/kg body weight) on eight occasions at monthly intervals.

Dosage

For oral use. The flavoured veterinary medicinal product should be administered according to the following table to ensure a single dose of 6 to 24 mg lotilaner/kg body weight. Cat body weight: 0.5-2.0 kg. Strength and number of tablets to be administered. AdTab 12 mg: 1. Cat body weight: >2.0-8.0 kg. Strength and number of tablets to be administered. AdTab 48 mg: 1. Cat body weight: >8.0 kg. Strength and number of tablets to be administered: appropriate combination of tablets. In cats weighing more than 8 kg, use an appropriate combination of the available strengths to achieve the recommended dose of 6-24 mg/kg. Underdosing could result in ineffective use and may favour the development of resistance. To ensure correct dosing, body weight should be determined as accurately as possible. Administer the veterinary medicinal product with food or within 30 minutes of feeding. For optimal control of tick and flea infestations, the veterinary medicinal product should be administered at monthly intervals and continued throughout the flea and/or tick season, based on the local epidemiological situation.

Storage

This veterinary medicinal product does not require any special storage conditions. Shelf life of the veterinary medicinal product as packaged for sale: 3 years.

Warnings

Parasites need to start feeding on the host to become exposed to lotilaner; therefore the risk of transmission of parasite-borne diseases cannot be completely excluded. The possibility that other animals in the same household may be a source of flea reinfestation should be considered, and these should be treated as necessary with an appropriate product. Fleas, at every stage of their development, can infest the cat's bedding and usual resting areas such as carpets and soft furnishings. In case of massive flea infestation, and at the start of control measures, these areas should be treated with a suitable environmental product and then cleaned regularly. Acceptable levels of efficacy may not be achieved if the veterinary medicinal product is not administered with food or within 30 minutes of feeding. Due to insufficient data supporting efficacy against ticks in young cats, this product is not recommended for the treatment of ticks in kittens aged 5 months or younger. Special precautions for safe use in the target species: safety and efficacy data have been studied in cats aged 8 weeks or older with a body weight of 0.5 kg or more. In the absence of available data, a veterinary surgeon should be consulted before treating kittens younger than 8 weeks or weighing less than 0.5 kg. Special precautions to be taken by the person administering the veterinary medicinal product to animals: wash hands after handling the product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the doctor. Special precautions for the protection of the environment: not applicable. No adverse reactions were observed following oral administration to 8-week-old kittens weighing 0.5 kg that were treated with doses more than 5 times the maximum recommended dose (130 mg lotilaner/kg body weight) on eight occasions at monthly intervals. Incompatibilities: not applicable.

Withdrawal Periods

Not applicable.

Target Species

Cat.

Interactions

None known. During clinical field studies, no interactions were observed between lotilaner and routinely used veterinary medicinal products.

Diagnosis and Prescription

Veterinary medicinal product not subject to prescription.

Adverse Effects

Target species. Cats. Very rare (<1 animal / 10,000 animals treated, including isolated reports): vomiting ^1. ^1 Usually resolves without treatment. Reporting adverse events is important as it allows continuous monitoring of the safety of a veterinary medicinal product. Reports should be sent, preferably via a veterinary surgeon, to the marketing authorisation holder or to the national competent authority via the national reporting system. See also the "Contact details" section of the package leaflet.

Pregnancy and Lactation

The safety of the veterinary medicinal product during pregnancy or lactation has not been established. Pregnancy and lactation: laboratory studies in rats have not produced any evidence of teratogenic effects or adverse effects on the reproductive capacity of males and females. Consult a veterinary surgeon before use during pregnancy and lactation. Fertility: consult a veterinary surgeon before use in breeding cats.

Product Details

Format
CHEWABLE TABLETS
442 Items
5420036974383

10 other products in the same category:

Product added to wishlist
Product added to compare.